Updated from 1:49 p.m. EST
Shares of drug company
, which announced it had named Big Mac maker
Chief Operating Officer Ralph Alvarez to its board, were falling 0.5% to $34.40.
"Ralph truly understands and appreciates the value of building a successful, global customer-focused enterprise," said Lilly CEO John Lechleiter in a press release Wednesday. "His experience and insights will surely benefit Lilly shareholders as we continue to transform our company and deliver on our mission to provide improved outcomes for individual patients."
shares rose 0.8% to $33.68 a day after an announcement that it had paid
$10 million for an operational milestone of cancer drug elesclomol.
Meanwhile, shares of
fell 0.6% to $14.16 after a Wisconsin jury ruled late Monday that a company it had acquired had violated the state's Medicaid laws for years.
was falling 1.6% to $20.92, and
was hovering near the flat line at $28.64.